A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to changes in the cardiac energy metabolism that can lead to a loss of metabolic flexibility and to unfavorable clinical outcomes. We conducted an association analysis of 31 ASCVD phenotypes and 97 whole blood amino acids, acylcarnitines and derived ratios in the LIFE-Adult (n = 9646) and LIFE-Heart (n = 5860) studies, respectively. In addition to hundreds of significant associations, a total of 62 associations of six phenotypes were found in both studies. Positive associations of various amino acids and a range of acylcarnitines with decreasing cardiovascular health indicate disruptions in mitochondrial, as well as peroxisomal fatty acid oxidation...
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Background Metabolomics, defined as the comprehensive identification and quantification of low-molec...
Background: Measurement of small molecules of intermediary metabolism is a method for characterizing...
Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' meta...
Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' meta...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
Background The study aimed to show the relationship between a large number of circulating metabolite...
BACKGROUND: Metabolomic profiling may have diagnostic and prognostic value in heart failure. This st...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Metabolomics is a promising technology for the application of translational medicine to cardiovascul...
AbstractBackgroundIdentification of novel biomarkers is needed to improve the diagnosis and prognosi...
An untargeted metabolomics approach allows for a better understanding and identification of new cand...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Background Metabolomics, defined as the comprehensive identification and quantification of low-molec...
Background: Measurement of small molecules of intermediary metabolism is a method for characterizing...
Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' meta...
Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' meta...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
Background The study aimed to show the relationship between a large number of circulating metabolite...
BACKGROUND: Metabolomic profiling may have diagnostic and prognostic value in heart failure. This st...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Metabolomics is a promising technology for the application of translational medicine to cardiovascul...
AbstractBackgroundIdentification of novel biomarkers is needed to improve the diagnosis and prognosi...
An untargeted metabolomics approach allows for a better understanding and identification of new cand...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Background Metabolomics, defined as the comprehensive identification and quantification of low-molec...